Drs. Zhehong Gan and Irene Marco-Rius Receive Prestigious Awards at the Joint ENC-ISMAR Conference 2025
ASILOMAR, California – April 7, 2025 – At this year's Joint ENC-ISMAR Conference 2025, two distinguished scientists have been recognized for their groundbreaking research contributions to the field of magnetic resonance.
Dr. Zhehong Gan from the National High Magnetic Field Laboratory (MagLab) in Tallahassee, Florida, has been awarded the 2025 Günther Laukien Prize, while Dr. Irene Marco-Rius from the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, Spain, has received the Anatole Abragam Prize. The Günther Laukien Prize, established in 1999, honors cutting-edge experimental NMR research with a high probability of enabling beneficial new applications, and is presented annually at the ENC. The Anatole Abragam Prize, established by ISMAR, recognizes young investigators in magnetic resonance for their novel and significant contributions.
Dr. Gan has made significant contributions to NMR spectroscopy, developing advanced techniques for studying complex materials. His extensive research at ultra-high magnetic fields has advanced the boundaries of solid-state NMR spectroscopy, enabling more detailed and precise molecular analysis. Dr. Gan’s recent accomplishments include work in high-resolution solid-state NMR, enhancing the ability to analyze molecular structures with unprecedented clarity. He has developed innovative methods for multi-dimensional NMR spectroscopy, facilitating detailed investigations of molecular dynamics and interactions. His work pushes the boundaries of NMR technology, making substantial impacts on both fundamental research and practical applications in materials science.
Dr. Irene Marco-Rius has been awarded the 2025 Anatole Abragam Prize for her original contributions to hyper-polarized magnetic resonance imaging and spectroscopy. Her pioneering work includes the use of magnetic resonance to study cells grown on chips (‘organ-on-a-chip’ models), allowing the ex vivo metabolic assessment of disease mechanisms and therapy responses in controlled microenvironments.
Dr. Marco-Rius's research develops tools based on magnetic resonance spectroscopy (MRS) and imaging (MRI) to gain insights into cellular metabolism and detect pathological changes, aiming to identify biomarkers of disease for early diagnosis and to evaluate treatment response after therapy administration. Her innovative methods have facilitated more detailed investigations of molecular dynamics and interactions, pushing the boundaries of NMR technology and making substantial impacts on fundamental research and practical applications in biomedical imaging.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Markus Ziegler
Sr. Director and Head of Group Marketing, Bruker BioSpin
T: +49 172 3733531
E: pr@bruker.com